Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)
Published July 30, 2025 · Recall initiated: June 30, 2025
Summary
FDA records drug Class II recall D-0541-2025, published July 30, 2025 and initiated June 30, 2025. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: 13,680 ampoules; Lot: Batch # 4IA0505, Exp 09/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
What to do
Voluntary: Firm initiated · Letter
Get an email if BUDESONIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUDESONIDE
- Manufacturer
- Cipla USA, Inc.
- Distributor
- Distributed Nationwide in the USA
- Lot
- Batch # 4IA0505, Exp 09/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABudesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules perJune 17, 2026
- FDABENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.July 30, 2025
- FDAMiddle East Coast brand Tahini Dip; NET WT: 6 OZ (170g); INGREDIENTS: TAHINI, ORGANIC LEMON JUICE, GARLIC,July 30, 2025
- FDAEVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by:July 30, 2025
- FDABudesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL,February 7, 2024
- FDABudesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single DoseOctober 5, 2022
Questions about this recall
Was Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton) recalled?
Yes. FDA published recall D-0541-2025 on July 30, 2025. Reported hazard: Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUDESONIDE.